HALO

Halozyme Therapeutics, Inc.

Health Care
52
/100
HOLD
Signal 2.0 composite score — 7-pillar quant rating updated daily.

Signal 2.0

7-Pillar Score Breakdown

Each pillar scores 0–100. The composite is a regime-weighted blend of all seven.

Fundamentals & Quality
57
Valuation
70
Technicals & Momentum
52
Sentiment & News
7
Earnings Quality
76
Risk Profile
63
Market Regime
50

Premium Insights

Deeper Analysis — Unlocking Soon

Advanced institutional-grade signals are coming to Quantex Premium. Join the waitlist for early access.

Institutional Flow Signal ★ PREMIUM
🔒 PREMIUM Unlock with Premium
Earnings Risk Score ★ PREMIUM
73
Risk Score / 100
MODERATE
EPS Beat Est.
Report in ~14 days
🔒 PREMIUM Unlock with Premium

Fundamentals

Key Metrics

Sourced from the daily universe scan. Open the terminal for the full financial deep-dive.

Market Cap
$8.9B
P/E Ratio
26.3x
Revenue Growth
+35.3%
EPS Growth
+31.2%
Profit Margin
23.1%
Beta
0.84

See the full picture for HALO.

Run live Signal 2.0 scoring, deep financial statements, DCF valuation, CAPM, and options pricing — free, no account required.

Open Full Analysis → Browse All Stocks